Multi-dimensional phenotyping: towards a new taxonomy for airway disease.
All the real knowledge which we possess, depends on methods by which we distinguish the similar from the dissimilar. The greater the number of natural distinctions this method comprehends the clearer becomes our idea of things. The more numerous the objects which employ our attention the more difficult it becomes to form such a method and the more necessary. Classification is a fundamental part of medicine. Diseases are often categorized according to pre-20th century descriptions and concepts of disease based on symptoms, signs and functional abnormalities rather than on underlying pathogenesis. Where the aetiology of disease has been revealed (for example in the infectious diseases) a more precise classification has become possible, but in the chronic inflammatory diseases, and in the inflammatory airway diseases in particular, where pathogenesis has been stubbornly difficult to elucidate, we still use broad descriptive terms such as asthma and chronic obstructive pulmonary disease, which defy precise definition because they encompass a wide spectrum of presentations and physiological and cellular abnormalities. It is our contention that these broad-brush terms have outlived their usefulness and that we should be looking to create a new taxonomy of airway disease-a taxonomy that more closely reflects the spectrum of phenotypes that are encompassed within the term airway inflammatory diseases, and that gives full recognition to late 20th and 21st century insights into the disordered physiology and cell biology that characterizes these conditions in the expectation that these will map more closely to both aetiology and response to treatment. Development of this taxonomy will require a much more complete and sophisticated correlation of the many variables that make up a condition than has been usual to employ in an approach that encompasses multi-dimensional phenotyping and uses complex statistical tools such as cluster analysis.
Wardlaw
A J
AJ
Department of Respiratory Medicine, Department of Infection Immunity and Inflammation and Institute for Lung Health, Leicester, UK. aw24@le.ac.uk
Silverman
M
M
Siva
R
R
Pavord
I D
ID
Green
R
R
D000818:Animals; D001249:Asthma / Q000145:classification; D016000:Cluster Analysis; D004195:Disease Models, Animal; D005260:Female; D006801:Humans; D008297:Male; D010641:Phenotype; D029424:Pulmonary Disease, Chronic Obstructive / Q000145:classification; D012120:Respiration Disorders / Q000145:classification* / Q000188:drug therapy / Q000503:physiopathology